Healthcare · Medical Devices
$21.82
+$0.04+0.18%
Delayed · · marketstack
17 open-market sales on file ($47.75M), none of them under a pre-arranged plan. Who, and when
−$3.25−12.96%over 1M
Price ÷ trailing earnings
Revenue grew +15.45% in FY2025, +6.58% faster than its sector. The median across Healthcare companies this platform tracks is +8.87%.
No comments yet
Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.
Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.
Updated · the last close
What KIDS has filed with the SEC. This is not Orthopediatrics Corp.’s own investor relations site: these filings are the primary source that site publishes from.
Also filed under Medical Devices, ranked by how closely they sit beside KIDS.
From Item 1A of its most recent 10-K, filed March 2026.
And 17 more.
Reimbursement
Additionally, because Medicaid is administered at the state level, there is considerable variability in how coverage and reimbursement policies are implemented. This variability introduces uncertainty in forecasting demand and reimbursement levels for our …7 more themes are on Measure
Free, no card, and it does not expire. See what the paid plans add
The assistant answers from what KIDS has actually filed: 11 annual reports filed with the SEC, 43 Form 4 filings from the last year and 3 funds that hold it. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.
Press one and the answer appears right here on the page, from KIDS's filings and figures. One a day without an account; a free account has its own, and no card.
See how much of Orthopediatrics Corp. each of these investors holds, and every quarter they moved.
Ten seconds. No card. Nothing to cancel.
Be told the moment a KIDS insider trades
Put Orthopediatrics Corp. on a watchlist for a free alert, the bell and a daily email, when a Form 4 worth a row is filed, with vesting and automatic tax sales already struck out so what lands is a decision, not paperwork.
The full filing historyMeasure
Ask what growth the price is already betting on
Orthopediatrics Corp.'s income statement, balance sheet and cash flow as filed, and the ratios computed from them, plus a reverse DCF that holds today's price fixed and solves for the growth it requires.
The reverse DCFMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: how big a bet each one is, and by how much it changed.
Every position, sizedMeasure
Interrogate the filing, not the internet
Ask anything about Orthopediatrics Corp.'s fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.
Free, no card, and it does not expire.
Free, no card, and it does not expire. See what the paid plans add
Out of 307 passages in this year’s Item 1A.
New this year
91 more passages are on Bespoke
Free, no card, and it does not expire. See what the paid plans add